SS
RCUS icon

Steve Schonfeld’s Arcus Biosciences RCUS Stock Holding History

Steve Schonfeld’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Sell
122,574
-70,987
-37% -$1.75M 0.01% 763
2026
Q1 		$4.18M Buy
193,561
+96,278
+99% +$2.08M 0.03% 549
2025
Q4 		$2.32M Buy
97,283
+48,389
+99% +$987K 0.01% 820
2025
Q3 		$665K Sell
48,894
-5,034
-9% -$52.3K ﹤0.01% 1560
2025
Q2 		$439K Sell
53,928
-82,560
-60% -$705K ﹤0.01% 1588
2025
Q1 		$1.07M Buy
136,488
+1,491
+1% +$17.3K 0.01% 1262
2024
Q4 		$2.01M Sell
134,997
-538,841
-80% -$8.8M 0.01% 827
2024
Q3 		$10.3M Buy
673,838
+441,044
+189% +$6.95M 0.07% 295
2024
Q2 		$3.55M Buy
232,794
+128,934
+124% +$2.08M 0.02% 671
2024
Q1 		$1.96M Sell
103,860
-126,960
-55% -$2.2M 0.01% 999
2023
Q4 		$4.41M Buy
230,820
+87,920
+62% +$1.41M 0.03% 550
2023
Q3 		$2.57M Sell
142,900
-40,124
-22% -$806K 0.02% 746
2023
Q2 		$3.72M Sell
183,024
-110,786
-38% -$2.11M 0.03% 571
2023
Q1 		$5.36M Buy
293,810
+139,471
+90% +$2.67M 0.05% 427
2022
Q4 		$3.19M Buy
154,339
+23,711
+18% +$652K 0.03% 640
2022
Q3 		$3.42M Sell
130,628
-34,960
-21% -$925K 0.03% 665
2022
Q2 		$4.2M Buy
+165,588
New +$4.06M 0.04% 522
2022
Q1 		– Sell
-24,900
Closed -$1.01M – 2869
2021
Q4 		$1.01M Buy
24,900
+500
+2% +$19.4K 0.01% 941
2021
Q3 		$851K Buy
+24,400
New +$759K 0.01% 1023
2021
Q2 		– Sell
-50,701
Closed -$1.42M – 2241
2021
Q1 		$1.42M Buy
50,701
+35,076
+224% +$1.22M 0.02% 770
2020
Q4 		$406K Buy
+15,625
New +$378K 0.01% 1108

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steve Schonfeld's RCUS Position: Q2 2026 in Review

Steve Schonfeld reduced its Arcus Biosciences (RCUS) stake by 37% in Q2 2026, selling an estimated $1.75M and leaving 122,574 shares worth $3.78M. The position accounts for 0.01% of the portfolio, ranked #763.

Steve Schonfeld first reported a position in RCUS in Q4 2020 and has held it in 21 quarters since. The position peaked at $10.3M in Q3 2024. 228 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Steve Schonfeld held 122,574 shares of Arcus Biosciences worth $3.78M as of Q2 2026.
  • Steve Schonfeld sold 70,987 Arcus Biosciences shares in Q2 2026, an estimated $1.75M.
  • Arcus Biosciences made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #763 holding.
  • Steve Schonfeld first reported a position in Arcus Biosciences in Q4 2020 and has held it in 21 quarters since.
  • Steve Schonfeld's Arcus Biosciences position peaked at $10.3M in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.